Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force


Smith E. M. D., Aggarwal A., Ainsworth J., Al-Abadi E., Avcin T., Bortey L., ...More

CLINICAL IMMUNOLOGY, vol.263, 2024 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 263
  • Publication Date: 2024
  • Doi Number: 10.1016/j.clim.2024.110214
  • Journal Name: CLINICAL IMMUNOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
  • Hacettepe University Affiliated: Yes

Abstract

Objective: To derive childhood -onset SLE (cSLE) specific remission definitions for future treat -to -target (T2T) trials, observational studies, and clinical practice. Methods: The cSLE International T2T Task Force conducted Delphi surveys exploring paediatric perspectives on adult -onset SLE remission targets. A modified nominal group technique was used to discuss, refine, and agree on the cSLE remission target criteria. Results: The Task Force proposed two definitions of remission: 'cSLE clinical remission on steroids (cCR) ' and 'cSLE clinical remission off steroids (cCR-0) '. The common criteria are: (1) Clinical-SLEDAI-2 K = 0; (2) PGA score < 0.5 (0 -3 scale); (4) stable antimalarials, immunosuppressive, and biologic therapy (changes due to sideeffects, adherence, weight, or when building up to target dose allowed). Criterion (3) in cCR is the prednisolone dose <= 0.1 mg/kg/day (maximum 5 mg/day), whereas in cCR-0 it is zero. Conclusions: cSLE definitions of remission have been proposed, maintaining sufficient alignment with the adultSLE definition to facilitate life -course research.